BioSpace News Archive

Cumulus Media raised a record-breaking $2.7 million during its annual radiothon season to support the lifesaving mission of St. Jude Children’s Research Hospital: Finding cures.

Innovative product portfolio based on TELA Bio’s proven technology platform advances the design of biologic-based materials for reconstructive surgery.

The Heavenly Shares were sold to accredited investors pursuant to applicable securities regulations and are subject to an indefinite hold period.

Chemistree Technology Inc., is pleased to provide shareholders with an update on the Company’s Washington State assets and its Desert Hot Springs, California cultivation facility development.

The Washington Mesothelioma Victims Center’s top priority is the best possible financial compensation settlement results for a person with mesothelioma or asbestos exposure lung cancer in Washington State.

Popular CBD Brands, the Internet’s leading website for CBD information and reviews, has published a page collecting the best CBD oil coupon codes found around the web in honor of 420 Day.

The Muscular Dystrophy Association has selected Tana Zwart to serve and represent families affected by muscular dystrophy and related neuromuscular diseases alongside existing national ambassadors, seven-year-old Faith Fortenberry of Waco, TX and 18-year-old Justin Moy of Concord, Mass.

Novasep, today announced the signing of a license agreement allowing Novasep to use Institut Pasteur’s DNA Flap Technology to produce GMP-grade lentiviral vectors for clinical use in all therapeutic applications including gene therapy, cell therapy, immunotherapy and vaccination, for any customer, worldwide

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced dosing of the first frontotemporal dementia (FTD) patient in the Phase 1b portion of the INFRONT clinical study of AL001 after successful completion of the healthy volunteer single ascending dose escalation portion of the study.

BioKansas is hosting the 2019 Kansas BioGENEius Challenge Finals on Thursday, April 25th, at the KU Edwards Campus. Biotechnology is the utilization of biological processes to develop technologies and products that improve lives and the health of the planet